BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34831379)

  • 1. Conditional CRISPR-Cas Genome Editing in
    Bahuguna S; Redhai S; Zhou J; Wang T; Port F; Boutros M
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional editing of the
    Wang BZ; Zhang C; Zhang JL; Sun J
    Yi Chuan; 2023 Jul; 45(7):593-601. PubMed ID: 37503583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large-scale resource for tissue-specific CRISPR mutagenesis in
    Port F; Strein C; Stricker M; Rauscher B; Heigwer F; Zhou J; Beyersdörffer C; Frei J; Hess A; Kern K; Lange L; Langner N; Malamud R; Pavlović B; Rädecke K; Schmitt L; Voos L; Valentini E; Boutros M
    Elife; 2020 Feb; 9():. PubMed ID: 32053108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized CRISPR/Cas tools for efficient germline and somatic genome engineering in Drosophila.
    Port F; Chen HM; Lee T; Bullock SL
    Proc Natl Acad Sci U S A; 2014 Jul; 111(29):E2967-76. PubMed ID: 25002478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome editing in Drosophila melanogaster: from basic genome engineering to the multipurpose CRISPR-Cas9 system.
    Ren X; Holsteens K; Li H; Sun J; Zhang Y; Liu LP; Liu Q; Ni JQ
    Sci China Life Sci; 2017 May; 60(5):476-489. PubMed ID: 28527116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-mediated genome editing in sea urchins.
    Lin CY; Oulhen N; Wessel G; Su YH
    Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulating plant RNA-silencing pathways to improve the gene editing efficiency of CRISPR/Cas9 systems.
    Mao Y; Yang X; Zhou Y; Zhang Z; Botella JR; Zhu JK
    Genome Biol; 2018 Sep; 19(1):149. PubMed ID: 30266091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex conditional mutagenesis in zebrafish using the CRISPR/Cas system.
    Yin L; Maddison LA; Chen W
    Methods Cell Biol; 2016; 135():3-17. PubMed ID: 27443918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 in plants: at play in the genome and at work for crop improvement.
    Hussain B; Lucas SJ; Budak H
    Brief Funct Genomics; 2018 Sep; 17(5):319-328. PubMed ID: 29912293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient Screening of CRISPR/Cas9-Induced Events in Drosophila Using a Co-CRISPR Strategy.
    Kane NS; Vora M; Varre KJ; Padgett RW
    G3 (Bethesda); 2017 Jan; 7(1):87-93. PubMed ID: 27793971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Models in Xenopus tropicalis by CRISPR/Cas9 Mediated Knockout of Tumor Suppressors.
    Naert T; Vleminckx K
    Methods Mol Biol; 2018; 1865():147-161. PubMed ID: 30151765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Employing CRISPR/Cas9 genome engineering to dissect the molecular requirements for mitosis.
    McKinley KL
    Methods Cell Biol; 2018; 144():75-105. PubMed ID: 29804684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina.
    Yang TC; Chang CY; Yarmishyn AA; Mao YS; Yang YP; Wang ML; Hsu CC; Yang HY; Hwang DK; Chen SJ; Tsai ML; Lai YH; Tzeng Y; Chang CC; Chiou SH
    Acta Biomater; 2020 Jan; 101():484-494. PubMed ID: 31672582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State-of-the-art CRISPR for in vivo and cell-based studies in Drosophila.
    Zirin J; Bosch J; Viswanatha R; Mohr SE; Perrimon N
    Trends Genet; 2022 May; 38(5):437-453. PubMed ID: 34933779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 Genome Editing to Study Nervous System Development in Drosophila.
    Fritsch C; Sprecher SG
    Methods Mol Biol; 2020; 2047():161-189. PubMed ID: 31552655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9-Mediated Genome Editing in the Filamentous Ascomycete Huntiella omanensis.
    Wilson AM; Wingfield BD
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32597846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-efficiency genome editing using a dmc1 promoter-controlled CRISPR/Cas9 system in maize.
    Feng C; Su H; Bai H; Wang R; Liu Y; Guo X; Liu C; Zhang J; Yuan J; Birchler JA; Han F
    Plant Biotechnol J; 2018 Nov; 16(11):1848-1857. PubMed ID: 29569825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-Enabled Multiplex Genome Editing and Its Application.
    Minkenberg B; Wheatley M; Yang Y
    Prog Mol Biol Transl Sci; 2017; 149():111-132. PubMed ID: 28712493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
    Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
    Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.